nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—Idarubicin—breast cancer	0.122	0.531	CrCtD
Daunorubicin—Anthracyclines—Idarubicin—breast cancer	0.0788	0.266	CiPCiCtD
Daunorubicin—Epirubicin—breast cancer	0.0561	0.244	CrCtD
Daunorubicin—Doxorubicin—breast cancer	0.0519	0.225	CrCtD
Daunorubicin—Topoisomerase Inhibitors—Idarubicin—breast cancer	0.0412	0.139	CiPCiCtD
Daunorubicin—Anthracyclines—Epirubicin—breast cancer	0.0362	0.122	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Mitoxantrone—breast cancer	0.035	0.118	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Irinotecan—breast cancer	0.035	0.118	CiPCiCtD
Daunorubicin—Anthracyclines—Doxorubicin—breast cancer	0.0335	0.113	CiPCiCtD
Daunorubicin—ABCC1—breast cancer	0.0262	0.253	CbGaD
Daunorubicin—Doxorubicin—Idarubicin—breast cancer	0.0262	0.177	CrCrCtD
Daunorubicin—Valrubicin—Idarubicin—breast cancer	0.0262	0.177	CrCrCtD
Daunorubicin—Epirubicin—Idarubicin—breast cancer	0.0262	0.177	CrCrCtD
Daunorubicin—TOP2A—breast cancer	0.0202	0.195	CbGaD
Daunorubicin—CYP1B1—breast cancer	0.0201	0.193	CbGaD
Daunorubicin—Topoisomerase Inhibitors—Epirubicin—breast cancer	0.0189	0.0639	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Doxorubicin—breast cancer	0.0175	0.0591	CiPCiCtD
Daunorubicin—ABCG2—breast cancer	0.0138	0.133	CbGaD
Daunorubicin—YWHAG—Epirubicin—breast cancer	0.0126	0.0879	CbGbCtD
Daunorubicin—Doxorubicin—Epirubicin—breast cancer	0.012	0.0812	CrCrCtD
Daunorubicin—Valrubicin—Epirubicin—breast cancer	0.012	0.0812	CrCrCtD
Daunorubicin—Idarubicin—Epirubicin—breast cancer	0.012	0.0812	CrCrCtD
Daunorubicin—Valrubicin—Doxorubicin—breast cancer	0.0111	0.0752	CrCrCtD
Daunorubicin—Epirubicin—Doxorubicin—breast cancer	0.0111	0.0752	CrCrCtD
Daunorubicin—Idarubicin—Doxorubicin—breast cancer	0.0111	0.0752	CrCrCtD
Daunorubicin—NR5A1—Vinblastine—breast cancer	0.0109	0.076	CbGbCtD
Daunorubicin—CYP1A1—breast cancer	0.0108	0.104	CbGaD
Daunorubicin—TOP2A—Idarubicin—breast cancer	0.00735	0.0513	CbGbCtD
Daunorubicin—CYP3A4—breast cancer	0.00691	0.0666	CbGaD
Daunorubicin—YWHAG—Doxorubicin—breast cancer	0.00669	0.0467	CbGbCtD
Daunorubicin—ABCB1—breast cancer	0.00576	0.0554	CbGaD
Daunorubicin—ABCC6—Vinblastine—breast cancer	0.00415	0.029	CbGbCtD
Daunorubicin—ABCC1—Idarubicin—breast cancer	0.00407	0.0284	CbGbCtD
Daunorubicin—ABCC10—Gemcitabine—breast cancer	0.00401	0.028	CbGbCtD
Daunorubicin—ABCC10—Paclitaxel—breast cancer	0.00362	0.0253	CbGbCtD
Daunorubicin—TOP2A—Mitoxantrone—breast cancer	0.00316	0.0221	CbGbCtD
Daunorubicin—CYP1A1—Toremifene—breast cancer	0.00304	0.0212	CbGbCtD
Daunorubicin—NR5A1—corpus luteum—breast cancer	0.00286	0.218	CbGeAlD
Daunorubicin—XDH—Carboplatin—breast cancer	0.00279	0.0195	CbGbCtD
Daunorubicin—POR—Doxorubicin—breast cancer	0.00278	0.0194	CbGbCtD
Daunorubicin—ABCC10—Docetaxel—breast cancer	0.00262	0.0183	CbGbCtD
Daunorubicin—TOP2A—Epirubicin—breast cancer	0.00256	0.0179	CbGbCtD
Daunorubicin—ABCC6—Doxorubicin—breast cancer	0.00255	0.0178	CbGbCtD
Daunorubicin—ABCB11—Tamoxifen—breast cancer	0.00253	0.0177	CbGbCtD
Daunorubicin—CYP1B1—Tamoxifen—breast cancer	0.00253	0.0177	CbGbCtD
Daunorubicin—CYP1B1—Mitoxantrone—breast cancer	0.00246	0.0172	CbGbCtD
Daunorubicin—ABCB11—Paclitaxel—breast cancer	0.00197	0.0137	CbGbCtD
Daunorubicin—CYP1B1—Paclitaxel—breast cancer	0.00197	0.0137	CbGbCtD
Daunorubicin—ABCC10—Doxorubicin—breast cancer	0.00195	0.0136	CbGbCtD
Daunorubicin—ABCC10—Methotrexate—breast cancer	0.00189	0.0132	CbGbCtD
Daunorubicin—ABCC1—Mitoxantrone—breast cancer	0.00175	0.0122	CbGbCtD
Daunorubicin—ABCB11—Vinblastine—breast cancer	0.00173	0.0121	CbGbCtD
Daunorubicin—XDH—Doxorubicin—breast cancer	0.0016	0.0111	CbGbCtD
Daunorubicin—CYP1A2—Anastrozole—breast cancer	0.00148	0.0104	CbGbCtD
Daunorubicin—CYP1B1—Docetaxel—breast cancer	0.00142	0.00993	CbGbCtD
Daunorubicin—ABCC1—Epirubicin—breast cancer	0.00142	0.0099	CbGbCtD
Daunorubicin—ABCC1—Paclitaxel—breast cancer	0.0014	0.00976	CbGbCtD
Daunorubicin—ABCC1—Irinotecan—breast cancer	0.00138	0.00963	CbGbCtD
Daunorubicin—TOP2A—Doxorubicin—breast cancer	0.00136	0.00949	CbGbCtD
Daunorubicin—CYP1A2—Toremifene—breast cancer	0.00136	0.00947	CbGbCtD
Daunorubicin—CYP3A5—Lapatinib—breast cancer	0.00133	0.00929	CbGbCtD
Daunorubicin—ABCC2—Tamoxifen—breast cancer	0.00133	0.00928	CbGbCtD
Daunorubicin—ABCC1—Vinblastine—breast cancer	0.00123	0.00856	CbGbCtD
Daunorubicin—ABCG2—Tamoxifen—breast cancer	0.0012	0.00839	CbGbCtD
Daunorubicin—ABCB1—Toremifene—breast cancer	0.00119	0.00828	CbGbCtD
Daunorubicin—ABCG2—Mitoxantrone—breast cancer	0.00117	0.00818	CbGbCtD
Daunorubicin—SLC22A2—Vinblastine—breast cancer	0.00111	0.00776	CbGbCtD
Daunorubicin—CYP1A1—Tamoxifen—breast cancer	0.00111	0.00775	CbGbCtD
Daunorubicin—ABCB11—Doxorubicin—breast cancer	0.00106	0.0074	CbGbCtD
Daunorubicin—CYP1B1—Doxorubicin—breast cancer	0.00106	0.0074	CbGbCtD
Daunorubicin—ABCC2—Paclitaxel—breast cancer	0.00103	0.00722	CbGbCtD
Daunorubicin—CYP3A4—Exemestane—breast cancer	0.00103	0.00716	CbGbCtD
Daunorubicin—ABCC2—Irinotecan—breast cancer	0.00102	0.00713	CbGbCtD
Daunorubicin—ABCC1—Docetaxel—breast cancer	0.00101	0.00706	CbGbCtD
Daunorubicin—ABCC2—Carboplatin—breast cancer	0.000973	0.0068	CbGbCtD
Daunorubicin—ABCG2—Paclitaxel—breast cancer	0.000935	0.00653	CbGbCtD
Daunorubicin—ABCG2—Irinotecan—breast cancer	0.000922	0.00644	CbGbCtD
Daunorubicin—ABCC2—Vinblastine—breast cancer	0.000907	0.00634	CbGbCtD
Daunorubicin—ABCG2—Fluorouracil—breast cancer	0.000885	0.00618	CbGbCtD
Daunorubicin—ABCG2—Carboplatin—breast cancer	0.00088	0.00615	CbGbCtD
Daunorubicin—CYP3A4—Letrozole—breast cancer	0.000872	0.00609	CbGbCtD
Daunorubicin—ABCB1—Lapatinib—breast cancer	0.000865	0.00604	CbGbCtD
Daunorubicin—CYP3A4—Anastrozole—breast cancer	0.000777	0.00543	CbGbCtD
Daunorubicin—ABCC1—Doxorubicin—breast cancer	0.000753	0.00526	CbGbCtD
Daunorubicin—ABCC2—Docetaxel—breast cancer	0.000748	0.00522	CbGbCtD
Daunorubicin—ABCC1—Methotrexate—breast cancer	0.000729	0.0051	CbGbCtD
Daunorubicin—CYP3A4—Toremifene—breast cancer	0.00071	0.00496	CbGbCtD
Daunorubicin—ABCG2—Docetaxel—breast cancer	0.000676	0.00472	CbGbCtD
Daunorubicin—CYP3A5—Tamoxifen—breast cancer	0.000666	0.00465	CbGbCtD
Daunorubicin—CYP3A4—Fulvestrant—breast cancer	0.000661	0.00461	CbGbCtD
Daunorubicin—CYP3A4—Thiotepa—breast cancer	0.000589	0.00411	CbGbCtD
Daunorubicin—ABCC2—Doxorubicin—breast cancer	0.000557	0.00389	CbGbCtD
Daunorubicin—ABCC2—Methotrexate—breast cancer	0.00054	0.00377	CbGbCtD
Daunorubicin—CYP3A4—Ixabepilone—breast cancer	0.000538	0.00376	CbGbCtD
Daunorubicin—CYP3A4—Lapatinib—breast cancer	0.000518	0.00362	CbGbCtD
Daunorubicin—CYP3A5—Paclitaxel—breast cancer	0.000518	0.00362	CbGbCtD
Daunorubicin—CYP3A5—Irinotecan—breast cancer	0.000511	0.00357	CbGbCtD
Daunorubicin—ABCG2—Doxorubicin—breast cancer	0.000504	0.00352	CbGbCtD
Daunorubicin—CYP1A2—Tamoxifen—breast cancer	0.000495	0.00346	CbGbCtD
Daunorubicin—ABCG2—Methotrexate—breast cancer	0.000488	0.00341	CbGbCtD
Daunorubicin—ABCB1—Vinorelbine—breast cancer	0.00048	0.00335	CbGbCtD
Daunorubicin—ABCB1—Tamoxifen—breast cancer	0.000433	0.00303	CbGbCtD
Daunorubicin—ABCB1—Mitoxantrone—breast cancer	0.000422	0.00295	CbGbCtD
Daunorubicin—CYP3A4—Raloxifene—breast cancer	0.000393	0.00274	CbGbCtD
Daunorubicin—CYP3A5—Docetaxel—breast cancer	0.000375	0.00262	CbGbCtD
Daunorubicin—ABCB1—Gemcitabine—breast cancer	0.000373	0.00261	CbGbCtD
Daunorubicin—CYP1A2—Fluorouracil—breast cancer	0.000365	0.00255	CbGbCtD
Daunorubicin—ABCB1—Paclitaxel—breast cancer	0.000337	0.00236	CbGbCtD
Daunorubicin—ABCB1—Irinotecan—breast cancer	0.000333	0.00232	CbGbCtD
Daunorubicin—ABCB1—Vinblastine—breast cancer	0.000296	0.00207	CbGbCtD
Daunorubicin—YWHAG—mammary gland—breast cancer	0.000292	0.0223	CbGeAlD
Daunorubicin—CYP3A4—Vinorelbine—breast cancer	0.000288	0.00201	CbGbCtD
Daunorubicin—TOP2B—mammary gland—breast cancer	0.000282	0.0215	CbGeAlD
Daunorubicin—CYP3A4—Tamoxifen—breast cancer	0.00026	0.00181	CbGbCtD
Daunorubicin—CYP3A4—Mitoxantrone—breast cancer	0.000253	0.00177	CbGbCtD
Daunorubicin—ABCB1—Docetaxel—breast cancer	0.000244	0.0017	CbGbCtD
Daunorubicin—YWHAG—nipple—breast cancer	0.000242	0.0184	CbGeAlD
Daunorubicin—TOP2B—nipple—breast cancer	0.000233	0.0178	CbGeAlD
Daunorubicin—TOP2B—Topotecan—Irinotecan—breast cancer	0.000233	0.366	CbGdCrCtD
Daunorubicin—CYP3A4—Paclitaxel—breast cancer	0.000202	0.00141	CbGbCtD
Daunorubicin—NR5A1—pituitary gland—breast cancer	0.0002	0.0152	CbGeAlD
Daunorubicin—CYP3A4—Irinotecan—breast cancer	0.000199	0.00139	CbGbCtD
Daunorubicin—TOP2B—embryo—breast cancer	0.000192	0.0147	CbGeAlD
Daunorubicin—Doxorubicin—NDUFS3—breast cancer	0.000189	0.155	CrCbGaD
Daunorubicin—POR—nipple—breast cancer	0.000184	0.014	CbGeAlD
Daunorubicin—NR5A1—female reproductive system—breast cancer	0.000183	0.014	CbGeAlD
Daunorubicin—ABCB1—Doxorubicin—breast cancer	0.000182	0.00127	CbGbCtD
Daunorubicin—NR5A1—adrenal gland—breast cancer	0.000179	0.0136	CbGeAlD
Daunorubicin—CYP3A4—Vinblastine—breast cancer	0.000177	0.00124	CbGbCtD
Daunorubicin—ABCB1—Methotrexate—breast cancer	0.000176	0.00123	CbGbCtD
Daunorubicin—TOP2A—nipple—breast cancer	0.000171	0.0131	CbGeAlD
Daunorubicin—NR5A1—female gonad—breast cancer	0.000167	0.0127	CbGeAlD
Daunorubicin—NR5A1—endocrine gland—breast cancer	0.000155	0.0118	CbGeAlD
Daunorubicin—CYP3A4—Docetaxel—breast cancer	0.000146	0.00102	CbGbCtD
Daunorubicin—YWHAG—endometrium—breast cancer	0.000146	0.0111	CbGeAlD
Daunorubicin—ABCC10—nipple—breast cancer	0.000146	0.0111	CbGeAlD
Daunorubicin—XDH—endometrium—breast cancer	0.000142	0.0109	CbGeAlD
Daunorubicin—TOP2B—endometrium—breast cancer	0.000141	0.0107	CbGeAlD
Daunorubicin—ABCC6—adipose tissue—breast cancer	0.00014	0.0107	CbGeAlD
Daunorubicin—CYP1B1—mammary gland—breast cancer	0.000139	0.0106	CbGeAlD
Daunorubicin—Epirubicin—AURKA—breast cancer	0.000137	0.112	CrCbGaD
Daunorubicin—YWHAG—uterus—breast cancer	0.000135	0.0103	CbGeAlD
Daunorubicin—YWHAG—pituitary gland—breast cancer	0.000132	0.0101	CbGeAlD
Daunorubicin—YWHAG—adipose tissue—breast cancer	0.000132	0.01	CbGeAlD
Daunorubicin—TOP2B—uterus—breast cancer	0.00013	0.00988	CbGeAlD
Daunorubicin—TOP2B—pituitary gland—breast cancer	0.000127	0.0097	CbGeAlD
Daunorubicin—TOP2B—adipose tissue—breast cancer	0.000127	0.00966	CbGeAlD
Daunorubicin—Valrubicin—TOP2A—breast cancer	0.000126	0.104	CrCbGaD
Daunorubicin—YWHAG—female reproductive system—breast cancer	0.000121	0.00922	CbGeAlD
Daunorubicin—YWHAG—adrenal gland—breast cancer	0.000118	0.009	CbGeAlD
Daunorubicin—XDH—female reproductive system—breast cancer	0.000118	0.00899	CbGeAlD
Daunorubicin—TOP2B—female reproductive system—breast cancer	0.000117	0.00888	CbGeAlD
Daunorubicin—YWHAG—bone marrow—breast cancer	0.000114	0.0087	CbGeAlD
Daunorubicin—TOP2B—adrenal gland—breast cancer	0.000114	0.00867	CbGeAlD
Daunorubicin—POR—endometrium—breast cancer	0.000111	0.00846	CbGeAlD
Daunorubicin—YWHAG—female gonad—breast cancer	0.00011	0.00839	CbGeAlD
Daunorubicin—TOP2B—bone marrow—breast cancer	0.00011	0.00839	CbGeAlD
Daunorubicin—CYP3A4—Doxorubicin—breast cancer	0.000109	0.000761	CbGbCtD
Daunorubicin—ABCC6—endocrine gland—breast cancer	0.000109	0.00828	CbGeAlD
Daunorubicin—TOP2B—female gonad—breast cancer	0.000106	0.00808	CbGeAlD
Daunorubicin—TOP2A—endometrium—breast cancer	0.000103	0.00789	CbGeAlD
Daunorubicin—ABCC1—nipple—breast cancer	0.000103	0.00786	CbGeAlD
Daunorubicin—YWHAG—endocrine gland—breast cancer	0.000102	0.0078	CbGeAlD
Daunorubicin—POR—pituitary gland—breast cancer	0.0001	0.00766	CbGeAlD
Daunorubicin—POR—adipose tissue—breast cancer	0.0001	0.00762	CbGeAlD
Daunorubicin—XDH—endocrine gland—breast cancer	9.98e-05	0.00761	CbGeAlD
Daunorubicin—TOP2B—endocrine gland—breast cancer	9.86e-05	0.00752	CbGeAlD
Daunorubicin—ABCB11—endocrine gland—breast cancer	9.75e-05	0.00743	CbGeAlD
Daunorubicin—TOP2A—uterus—breast cancer	9.53e-05	0.00727	CbGeAlD
Daunorubicin—Idarubicin—ABCC1—breast cancer	9.39e-05	0.0771	CrCbGaD
Daunorubicin—TOP2A—adipose tissue—breast cancer	9.32e-05	0.00711	CbGeAlD
Daunorubicin—POR—adrenal gland—breast cancer	8.97e-05	0.00684	CbGeAlD
Daunorubicin—ABCC10—endometrium—breast cancer	8.81e-05	0.00671	CbGeAlD
Daunorubicin—Epirubicin—PLA2G4A—breast cancer	8.81e-05	0.0724	CrCbGaD
Daunorubicin—POR—bone marrow—breast cancer	8.68e-05	0.00662	CbGeAlD
Daunorubicin—POR—female gonad—breast cancer	8.37e-05	0.00638	CbGeAlD
Daunorubicin—TOP2A—adrenal gland—breast cancer	8.36e-05	0.00637	CbGeAlD
Daunorubicin—CYP1A2—nipple—breast cancer	8.22e-05	0.00627	CbGeAlD
Daunorubicin—ABCC10—uterus—breast cancer	8.12e-05	0.00619	CbGeAlD
Daunorubicin—CYP1A1—nipple—breast cancer	8.11e-05	0.00618	CbGeAlD
Daunorubicin—TOP2A—bone marrow—breast cancer	8.09e-05	0.00617	CbGeAlD
Daunorubicin—ABCC10—pituitary gland—breast cancer	7.97e-05	0.00607	CbGeAlD
Daunorubicin—ABCC10—adipose tissue—breast cancer	7.94e-05	0.00605	CbGeAlD
Daunorubicin—Doxorubicin—AURKA—breast cancer	7.85e-05	0.0645	CrCbGaD
Daunorubicin—TOP2A—female gonad—breast cancer	7.8e-05	0.00594	CbGeAlD
Daunorubicin—POR—endocrine gland—breast cancer	7.78e-05	0.00593	CbGeAlD
Daunorubicin—CYP1B1—skin of body—breast cancer	7.35e-05	0.0056	CbGeAlD
Daunorubicin—ABCC10—female reproductive system—breast cancer	7.3e-05	0.00556	CbGeAlD
Daunorubicin—Idarubicin—TOP2A—breast cancer	7.24e-05	0.0595	CrCbGaD
Daunorubicin—ABCC10—adrenal gland—breast cancer	7.12e-05	0.00543	CbGeAlD
Daunorubicin—Epirubicin—ABCC1—breast cancer	7.12e-05	0.0585	CrCbGaD
Daunorubicin—YWHAG—lymph node—breast cancer	7.08e-05	0.00539	CbGeAlD
Daunorubicin—ABCC10—bone marrow—breast cancer	6.89e-05	0.00525	CbGeAlD
Daunorubicin—TOP2B—lymph node—breast cancer	6.82e-05	0.0052	CbGeAlD
Daunorubicin—ABCC10—female gonad—breast cancer	6.64e-05	0.00506	CbGeAlD
Daunorubicin—CYP1B1—uterus—breast cancer	6.38e-05	0.00486	CbGeAlD
Daunorubicin—CYP1B1—pituitary gland—breast cancer	6.27e-05	0.00478	CbGeAlD
Daunorubicin—CYP1B1—adipose tissue—breast cancer	6.24e-05	0.00476	CbGeAlD
Daunorubicin—ABCC1—endometrium—breast cancer	6.23e-05	0.00475	CbGeAlD
Daunorubicin—ABCC10—endocrine gland—breast cancer	6.17e-05	0.00471	CbGeAlD
Daunorubicin—ABCC2—female reproductive system—breast cancer	5.86e-05	0.00447	CbGeAlD
Daunorubicin—ABCC1—uterus—breast cancer	5.74e-05	0.00438	CbGeAlD
Daunorubicin—CYP1B1—female reproductive system—breast cancer	5.74e-05	0.00437	CbGeAlD
Daunorubicin—ABCC2—adrenal gland—breast cancer	5.72e-05	0.00436	CbGeAlD
Daunorubicin—ABCC1—pituitary gland—breast cancer	5.64e-05	0.0043	CbGeAlD
Daunorubicin—ABCC1—adipose tissue—breast cancer	5.61e-05	0.00428	CbGeAlD
Daunorubicin—CYP1B1—adrenal gland—breast cancer	5.6e-05	0.00427	CbGeAlD
Daunorubicin—Epirubicin—TOP2A—breast cancer	5.49e-05	0.0451	CrCbGaD
Daunorubicin—CYP1A1—epithelium—breast cancer	5.46e-05	0.00416	CbGeAlD
Daunorubicin—POR—lymph node—breast cancer	5.38e-05	0.0041	CbGeAlD
Daunorubicin—TOP2A—Docetaxel—Paclitaxel—breast cancer	5.29e-05	0.0832	CbGdCrCtD
Daunorubicin—CYP1B1—female gonad—breast cancer	5.22e-05	0.00398	CbGeAlD
Daunorubicin—CYP1A1—skin of body—breast cancer	5.19e-05	0.00396	CbGeAlD
Daunorubicin—TOP2A—Gefitinib—Lapatinib—breast cancer	5.18e-05	0.0816	CbGdCrCtD
Daunorubicin—ABCG2—endometrium—breast cancer	5.16e-05	0.00393	CbGeAlD
Daunorubicin—ABCC1—adrenal gland—breast cancer	5.04e-05	0.00384	CbGeAlD
Daunorubicin—TOP2A—lymph node—breast cancer	5.01e-05	0.00382	CbGeAlD
Daunorubicin—ABCC2—endocrine gland—breast cancer	4.96e-05	0.00378	CbGeAlD
Daunorubicin—CYP1B1—endocrine gland—breast cancer	4.86e-05	0.0037	CbGeAlD
Daunorubicin—ABCG2—uterus—breast cancer	4.75e-05	0.00362	CbGeAlD
Daunorubicin—ABCC1—female gonad—breast cancer	4.7e-05	0.00358	CbGeAlD
Daunorubicin—ABCG2—pituitary gland—breast cancer	4.67e-05	0.00356	CbGeAlD
Daunorubicin—ABCG2—adipose tissue—breast cancer	4.65e-05	0.00354	CbGeAlD
Daunorubicin—CYP1A1—uterus—breast cancer	4.51e-05	0.00344	CbGeAlD
Daunorubicin—Doxorubicin—NQO1—breast cancer	4.51e-05	0.037	CrCbGaD
Daunorubicin—CYP1A1—adipose tissue—breast cancer	4.41e-05	0.00336	CbGeAlD
Daunorubicin—CYP3A5—adipose tissue—breast cancer	4.31e-05	0.00329	CbGeAlD
Daunorubicin—ABCC10—lymph node—breast cancer	4.27e-05	0.00325	CbGeAlD
Daunorubicin—ABCG2—adrenal gland—breast cancer	4.17e-05	0.00318	CbGeAlD
Daunorubicin—Doxorubicin—ABCC1—breast cancer	4.09e-05	0.0336	CrCbGaD
Daunorubicin—CYP1A1—female reproductive system—breast cancer	4.06e-05	0.00309	CbGeAlD
Daunorubicin—ABCG2—bone marrow—breast cancer	4.03e-05	0.00307	CbGeAlD
Daunorubicin—ABCG2—female gonad—breast cancer	3.89e-05	0.00296	CbGeAlD
Daunorubicin—Doxorubicin—NOS3—breast cancer	3.81e-05	0.0313	CrCbGaD
Daunorubicin—TOP2A—Topotecan—Irinotecan—breast cancer	3.76e-05	0.0592	CbGdCrCtD
Daunorubicin—CYP1A1—female gonad—breast cancer	3.69e-05	0.00281	CbGeAlD
Daunorubicin—Doxorubicin—NOS2—breast cancer	3.68e-05	0.0302	CrCbGaD
Daunorubicin—CYP3A5—female gonad—breast cancer	3.61e-05	0.00275	CbGeAlD
Daunorubicin—CYP1A2—endocrine gland—breast cancer	3.48e-05	0.00265	CbGeAlD
Daunorubicin—ABCB1—embryo—breast cancer	3.48e-05	0.00265	CbGeAlD
Daunorubicin—CYP1A1—endocrine gland—breast cancer	3.43e-05	0.00262	CbGeAlD
Daunorubicin—ABCC2—lymph node—breast cancer	3.43e-05	0.00261	CbGeAlD
Daunorubicin—TOP2A—Vindesine—Vinorelbine—breast cancer	3.36e-05	0.0529	CbGdCrCtD
Daunorubicin—CYP1B1—lymph node—breast cancer	3.36e-05	0.00256	CbGeAlD
Daunorubicin—CYP3A5—endocrine gland—breast cancer	3.36e-05	0.00256	CbGeAlD
Daunorubicin—Doxorubicin—TOP2A—breast cancer	3.15e-05	0.0259	CrCbGaD
Daunorubicin—Doxorubicin—CYP1B1—breast cancer	3.12e-05	0.0257	CrCbGaD
Daunorubicin—ABCC1—lymph node—breast cancer	3.02e-05	0.0023	CbGeAlD
Daunorubicin—CYP3A4—female reproductive system—breast cancer	2.98e-05	0.00227	CbGeAlD
Daunorubicin—Idarubicin—CYP2D6—breast cancer	2.89e-05	0.0237	CrCbGaD
Daunorubicin—ABCB1—epithelium—breast cancer	2.84e-05	0.00216	CbGeAlD
Daunorubicin—TOP2A—Vindesine—Vinblastine—breast cancer	2.69e-05	0.0423	CbGdCrCtD
Daunorubicin—TOP2A—Paclitaxel—Docetaxel—breast cancer	2.64e-05	0.0415	CbGdCrCtD
Daunorubicin—ABCB1—endometrium—breast cancer	2.54e-05	0.00194	CbGeAlD
Daunorubicin—CYP3A4—endocrine gland—breast cancer	2.52e-05	0.00192	CbGeAlD
Daunorubicin—ABCG2—lymph node—breast cancer	2.5e-05	0.0019	CbGeAlD
Daunorubicin—CYP1A1—lymph node—breast cancer	2.37e-05	0.00181	CbGeAlD
Daunorubicin—ABCB1—uterus—breast cancer	2.34e-05	0.00179	CbGeAlD
Daunorubicin—ABCB1—pituitary gland—breast cancer	2.3e-05	0.00175	CbGeAlD
Daunorubicin—ABCB1—adipose tissue—breast cancer	2.29e-05	0.00175	CbGeAlD
Daunorubicin—Doxorubicin—ABCG2—breast cancer	2.15e-05	0.0177	CrCbGaD
Daunorubicin—ABCB1—female reproductive system—breast cancer	2.11e-05	0.00161	CbGeAlD
Daunorubicin—ABCB1—adrenal gland—breast cancer	2.06e-05	0.00157	CbGeAlD
Daunorubicin—ABCB1—bone marrow—breast cancer	1.99e-05	0.00152	CbGeAlD
Daunorubicin—TOP2A—Doxorubicin—Idarubicin—breast cancer	1.92e-05	0.0303	CbGdCrCtD
Daunorubicin—TOP2A—Epirubicin—Idarubicin—breast cancer	1.92e-05	0.0303	CbGdCrCtD
Daunorubicin—ABCB1—female gonad—breast cancer	1.92e-05	0.00146	CbGeAlD
Daunorubicin—TOP2A—Vincristine—Vinorelbine—breast cancer	1.81e-05	0.0286	CbGdCrCtD
Daunorubicin—ABCB1—endocrine gland—breast cancer	1.78e-05	0.00136	CbGeAlD
Daunorubicin—TOP2A—Vinorelbine—Vinblastine—breast cancer	1.7e-05	0.0267	CbGdCrCtD
Daunorubicin—TOP2A—Vinblastine—Vinorelbine—breast cancer	1.46e-05	0.023	CbGdCrCtD
Daunorubicin—TOP2A—Vincristine—Vinblastine—breast cancer	1.45e-05	0.0228	CbGdCrCtD
Daunorubicin—Doxorubicin—CYP2D6—breast cancer	1.26e-05	0.0103	CrCbGaD
Daunorubicin—ABCB1—lymph node—breast cancer	1.23e-05	0.000939	CbGeAlD
Daunorubicin—TOP2A—Methyltestosterone—Fluoxymesterone—breast cancer	1.22e-05	0.0192	CbGdCrCtD
Daunorubicin—Doxorubicin—CYP3A4—breast cancer	1.08e-05	0.00885	CrCbGaD
Daunorubicin—TOP2A—Cytarabine—Gemcitabine—breast cancer	9.53e-06	0.015	CbGdCrCtD
Daunorubicin—Doxorubicin—ABCB1—breast cancer	8.97e-06	0.00737	CrCbGaD
Daunorubicin—TOP2A—Idarubicin—Epirubicin—breast cancer	8.84e-06	0.0139	CbGdCrCtD
Daunorubicin—TOP2A—Doxorubicin—Epirubicin—breast cancer	8.84e-06	0.0139	CbGdCrCtD
Daunorubicin—TOP2A—Epirubicin—Doxorubicin—breast cancer	8.18e-06	0.0129	CbGdCrCtD
Daunorubicin—TOP2A—Idarubicin—Doxorubicin—breast cancer	8.18e-06	0.0129	CbGdCrCtD
Daunorubicin—TOP2A—Norethindrone—Fluoxymesterone—breast cancer	7.96e-06	0.0125	CbGdCrCtD
Daunorubicin—TOP2A—Azacitidine—Gemcitabine—breast cancer	6.83e-06	0.0108	CbGdCrCtD
Daunorubicin—Rhinitis—Epirubicin—breast cancer	5.9e-06	0.000153	CcSEcCtD
Daunorubicin—Conjunctivitis—Doxorubicin—breast cancer	5.9e-06	0.000153	CcSEcCtD
Daunorubicin—Diarrhoea—Fluorouracil—breast cancer	5.88e-06	0.000152	CcSEcCtD
Daunorubicin—Thrombocytopenia—Capecitabine—breast cancer	5.88e-06	0.000152	CcSEcCtD
Daunorubicin—Tinnitus—Methotrexate—breast cancer	5.86e-06	0.000152	CcSEcCtD
Daunorubicin—Tachycardia—Capecitabine—breast cancer	5.86e-06	0.000152	CcSEcCtD
Daunorubicin—Cardiac disorder—Methotrexate—breast cancer	5.84e-06	0.000151	CcSEcCtD
Daunorubicin—Urticaria—Paclitaxel—breast cancer	5.81e-06	0.000151	CcSEcCtD
Daunorubicin—Hyperhidrosis—Capecitabine—breast cancer	5.8e-06	0.000151	CcSEcCtD
Daunorubicin—Body temperature increased—Paclitaxel—breast cancer	5.78e-06	0.00015	CcSEcCtD
Daunorubicin—Abdominal pain—Paclitaxel—breast cancer	5.78e-06	0.00015	CcSEcCtD
Daunorubicin—Anorexia—Capecitabine—breast cancer	5.72e-06	0.000148	CcSEcCtD
Daunorubicin—Vomiting—Irinotecan—breast cancer	5.7e-06	0.000148	CcSEcCtD
Daunorubicin—Vomiting—Mitoxantrone—breast cancer	5.7e-06	0.000148	CcSEcCtD
Daunorubicin—Sinusitis—Doxorubicin—breast cancer	5.69e-06	0.000148	CcSEcCtD
Daunorubicin—Dizziness—Fluorouracil—breast cancer	5.68e-06	0.000147	CcSEcCtD
Daunorubicin—Visual impairment—Epirubicin—breast cancer	5.67e-06	0.000147	CcSEcCtD
Daunorubicin—Rash—Mitoxantrone—breast cancer	5.65e-06	0.000147	CcSEcCtD
Daunorubicin—Rash—Irinotecan—breast cancer	5.65e-06	0.000147	CcSEcCtD
Daunorubicin—Dermatitis—Mitoxantrone—breast cancer	5.65e-06	0.000147	CcSEcCtD
Daunorubicin—Dermatitis—Irinotecan—breast cancer	5.65e-06	0.000147	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Docetaxel—breast cancer	5.65e-06	0.000147	CcSEcCtD
Daunorubicin—Chills—Methotrexate—breast cancer	5.64e-06	0.000146	CcSEcCtD
Daunorubicin—Headache—Mitoxantrone—breast cancer	5.62e-06	0.000146	CcSEcCtD
Daunorubicin—Headache—Irinotecan—breast cancer	5.62e-06	0.000146	CcSEcCtD
Daunorubicin—Insomnia—Docetaxel—breast cancer	5.61e-06	0.000145	CcSEcCtD
Daunorubicin—Alopecia—Methotrexate—breast cancer	5.56e-06	0.000144	CcSEcCtD
Daunorubicin—Vomiting—Gemcitabine—breast cancer	5.55e-06	0.000144	CcSEcCtD
Daunorubicin—Dyspnoea—Docetaxel—breast cancer	5.53e-06	0.000143	CcSEcCtD
Daunorubicin—Somnolence—Docetaxel—breast cancer	5.51e-06	0.000143	CcSEcCtD
Daunorubicin—Rash—Gemcitabine—breast cancer	5.51e-06	0.000143	CcSEcCtD
Daunorubicin—Dermatitis—Gemcitabine—breast cancer	5.5e-06	0.000143	CcSEcCtD
Daunorubicin—Tinnitus—Epirubicin—breast cancer	5.49e-06	0.000142	CcSEcCtD
Daunorubicin—Erythema—Methotrexate—breast cancer	5.47e-06	0.000142	CcSEcCtD
Daunorubicin—Headache—Gemcitabine—breast cancer	5.47e-06	0.000142	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Capecitabine—breast cancer	5.47e-06	0.000142	CcSEcCtD
Daunorubicin—Cardiac disorder—Epirubicin—breast cancer	5.46e-06	0.000142	CcSEcCtD
Daunorubicin—Flushing—Epirubicin—breast cancer	5.46e-06	0.000142	CcSEcCtD
Daunorubicin—Vomiting—Fluorouracil—breast cancer	5.46e-06	0.000142	CcSEcCtD
Daunorubicin—Rhinitis—Doxorubicin—breast cancer	5.46e-06	0.000142	CcSEcCtD
Daunorubicin—Insomnia—Capecitabine—breast cancer	5.43e-06	0.000141	CcSEcCtD
Daunorubicin—Rash—Fluorouracil—breast cancer	5.41e-06	0.00014	CcSEcCtD
Daunorubicin—Dermatitis—Fluorouracil—breast cancer	5.41e-06	0.00014	CcSEcCtD
Daunorubicin—Decreased appetite—Docetaxel—breast cancer	5.39e-06	0.00014	CcSEcCtD
Daunorubicin—Hypersensitivity—Paclitaxel—breast cancer	5.39e-06	0.00014	CcSEcCtD
Daunorubicin—Headache—Fluorouracil—breast cancer	5.38e-06	0.00014	CcSEcCtD
Daunorubicin—Dysgeusia—Methotrexate—breast cancer	5.36e-06	0.000139	CcSEcCtD
Daunorubicin—Dyspnoea—Capecitabine—breast cancer	5.35e-06	0.000139	CcSEcCtD
Daunorubicin—Fatigue—Docetaxel—breast cancer	5.34e-06	0.000139	CcSEcCtD
Daunorubicin—Nausea—Irinotecan—breast cancer	5.33e-06	0.000138	CcSEcCtD
Daunorubicin—Nausea—Mitoxantrone—breast cancer	5.33e-06	0.000138	CcSEcCtD
Daunorubicin—Constipation—Docetaxel—breast cancer	5.3e-06	0.000138	CcSEcCtD
Daunorubicin—Pain—Docetaxel—breast cancer	5.3e-06	0.000138	CcSEcCtD
Daunorubicin—Back pain—Methotrexate—breast cancer	5.29e-06	0.000137	CcSEcCtD
Daunorubicin—Chills—Epirubicin—breast cancer	5.28e-06	0.000137	CcSEcCtD
Daunorubicin—Arrhythmia—Epirubicin—breast cancer	5.26e-06	0.000136	CcSEcCtD
Daunorubicin—Visual impairment—Doxorubicin—breast cancer	5.25e-06	0.000136	CcSEcCtD
Daunorubicin—Asthenia—Paclitaxel—breast cancer	5.25e-06	0.000136	CcSEcCtD
Daunorubicin—Decreased appetite—Capecitabine—breast cancer	5.22e-06	0.000135	CcSEcCtD
Daunorubicin—Alopecia—Epirubicin—breast cancer	5.2e-06	0.000135	CcSEcCtD
Daunorubicin—Nausea—Gemcitabine—breast cancer	5.19e-06	0.000135	CcSEcCtD
Daunorubicin—Fatigue—Capecitabine—breast cancer	5.17e-06	0.000134	CcSEcCtD
Daunorubicin—Pruritus—Paclitaxel—breast cancer	5.17e-06	0.000134	CcSEcCtD
Daunorubicin—Pain—Capecitabine—breast cancer	5.13e-06	0.000133	CcSEcCtD
Daunorubicin—Constipation—Capecitabine—breast cancer	5.13e-06	0.000133	CcSEcCtD
Daunorubicin—Erythema—Epirubicin—breast cancer	5.12e-06	0.000133	CcSEcCtD
Daunorubicin—Feeling abnormal—Docetaxel—breast cancer	5.11e-06	0.000133	CcSEcCtD
Daunorubicin—Nausea—Fluorouracil—breast cancer	5.1e-06	0.000132	CcSEcCtD
Daunorubicin—Ill-defined disorder—Methotrexate—breast cancer	5.08e-06	0.000132	CcSEcCtD
Daunorubicin—Tinnitus—Doxorubicin—breast cancer	5.08e-06	0.000132	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Docetaxel—breast cancer	5.07e-06	0.000131	CcSEcCtD
Daunorubicin—Anaemia—Methotrexate—breast cancer	5.06e-06	0.000131	CcSEcCtD
Daunorubicin—Flushing—Doxorubicin—breast cancer	5.05e-06	0.000131	CcSEcCtD
Daunorubicin—Cardiac disorder—Doxorubicin—breast cancer	5.05e-06	0.000131	CcSEcCtD
Daunorubicin—Dysgeusia—Epirubicin—breast cancer	5.02e-06	0.00013	CcSEcCtD
Daunorubicin—Diarrhoea—Paclitaxel—breast cancer	5e-06	0.00013	CcSEcCtD
Daunorubicin—Back pain—Epirubicin—breast cancer	4.95e-06	0.000129	CcSEcCtD
Daunorubicin—Feeling abnormal—Capecitabine—breast cancer	4.94e-06	0.000128	CcSEcCtD
Daunorubicin—Malaise—Methotrexate—breast cancer	4.94e-06	0.000128	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Capecitabine—breast cancer	4.91e-06	0.000127	CcSEcCtD
Daunorubicin—Abdominal pain—Docetaxel—breast cancer	4.9e-06	0.000127	CcSEcCtD
Daunorubicin—Body temperature increased—Docetaxel—breast cancer	4.9e-06	0.000127	CcSEcCtD
Daunorubicin—Leukopenia—Methotrexate—breast cancer	4.9e-06	0.000127	CcSEcCtD
Daunorubicin—Chills—Doxorubicin—breast cancer	4.89e-06	0.000127	CcSEcCtD
Daunorubicin—Arrhythmia—Doxorubicin—breast cancer	4.86e-06	0.000126	CcSEcCtD
Daunorubicin—Dizziness—Paclitaxel—breast cancer	4.84e-06	0.000125	CcSEcCtD
Daunorubicin—Alopecia—Doxorubicin—breast cancer	4.81e-06	0.000125	CcSEcCtD
Daunorubicin—Cough—Methotrexate—breast cancer	4.78e-06	0.000124	CcSEcCtD
Daunorubicin—Urticaria—Capecitabine—breast cancer	4.77e-06	0.000124	CcSEcCtD
Daunorubicin—Ill-defined disorder—Epirubicin—breast cancer	4.75e-06	0.000123	CcSEcCtD
Daunorubicin—Body temperature increased—Capecitabine—breast cancer	4.74e-06	0.000123	CcSEcCtD
Daunorubicin—Abdominal pain—Capecitabine—breast cancer	4.74e-06	0.000123	CcSEcCtD
Daunorubicin—Convulsion—Methotrexate—breast cancer	4.74e-06	0.000123	CcSEcCtD
Daunorubicin—Erythema—Doxorubicin—breast cancer	4.74e-06	0.000123	CcSEcCtD
Daunorubicin—Anaemia—Epirubicin—breast cancer	4.73e-06	0.000123	CcSEcCtD
Daunorubicin—Agitation—Epirubicin—breast cancer	4.71e-06	0.000122	CcSEcCtD
Daunorubicin—Myalgia—Methotrexate—breast cancer	4.66e-06	0.000121	CcSEcCtD
Daunorubicin—Chest pain—Methotrexate—breast cancer	4.66e-06	0.000121	CcSEcCtD
Daunorubicin—Arthralgia—Methotrexate—breast cancer	4.66e-06	0.000121	CcSEcCtD
Daunorubicin—Vomiting—Paclitaxel—breast cancer	4.65e-06	0.000121	CcSEcCtD
Daunorubicin—Dysgeusia—Doxorubicin—breast cancer	4.64e-06	0.00012	CcSEcCtD
Daunorubicin—Malaise—Epirubicin—breast cancer	4.62e-06	0.00012	CcSEcCtD
Daunorubicin—Rash—Paclitaxel—breast cancer	4.61e-06	0.00012	CcSEcCtD
Daunorubicin—Dermatitis—Paclitaxel—breast cancer	4.61e-06	0.00012	CcSEcCtD
Daunorubicin—Discomfort—Methotrexate—breast cancer	4.6e-06	0.000119	CcSEcCtD
Daunorubicin—Syncope—Epirubicin—breast cancer	4.59e-06	0.000119	CcSEcCtD
Daunorubicin—Leukopenia—Epirubicin—breast cancer	4.59e-06	0.000119	CcSEcCtD
Daunorubicin—Back pain—Doxorubicin—breast cancer	4.58e-06	0.000119	CcSEcCtD
Daunorubicin—Headache—Paclitaxel—breast cancer	4.58e-06	0.000119	CcSEcCtD
Daunorubicin—Hypersensitivity—Docetaxel—breast cancer	4.57e-06	0.000118	CcSEcCtD
Daunorubicin—Palpitations—Epirubicin—breast cancer	4.53e-06	0.000117	CcSEcCtD
Daunorubicin—Confusional state—Methotrexate—breast cancer	4.5e-06	0.000117	CcSEcCtD
Daunorubicin—Loss of consciousness—Epirubicin—breast cancer	4.5e-06	0.000117	CcSEcCtD
Daunorubicin—Cough—Epirubicin—breast cancer	4.47e-06	0.000116	CcSEcCtD
Daunorubicin—Anaphylactic shock—Methotrexate—breast cancer	4.47e-06	0.000116	CcSEcCtD
Daunorubicin—Asthenia—Docetaxel—breast cancer	4.45e-06	0.000115	CcSEcCtD
Daunorubicin—Convulsion—Epirubicin—breast cancer	4.44e-06	0.000115	CcSEcCtD
Daunorubicin—Infection—Methotrexate—breast cancer	4.44e-06	0.000115	CcSEcCtD
Daunorubicin—Hypertension—Epirubicin—breast cancer	4.42e-06	0.000115	CcSEcCtD
Daunorubicin—Hypersensitivity—Capecitabine—breast cancer	4.42e-06	0.000115	CcSEcCtD
Daunorubicin—Ill-defined disorder—Doxorubicin—breast cancer	4.4e-06	0.000114	CcSEcCtD
Daunorubicin—Pruritus—Docetaxel—breast cancer	4.38e-06	0.000114	CcSEcCtD
Daunorubicin—Anaemia—Doxorubicin—breast cancer	4.38e-06	0.000114	CcSEcCtD
Daunorubicin—Thrombocytopenia—Methotrexate—breast cancer	4.37e-06	0.000113	CcSEcCtD
Daunorubicin—Chest pain—Epirubicin—breast cancer	4.36e-06	0.000113	CcSEcCtD
Daunorubicin—Arthralgia—Epirubicin—breast cancer	4.36e-06	0.000113	CcSEcCtD
Daunorubicin—Myalgia—Epirubicin—breast cancer	4.36e-06	0.000113	CcSEcCtD
Daunorubicin—Agitation—Doxorubicin—breast cancer	4.36e-06	0.000113	CcSEcCtD
Daunorubicin—Anxiety—Epirubicin—breast cancer	4.35e-06	0.000113	CcSEcCtD
Daunorubicin—Nausea—Paclitaxel—breast cancer	4.34e-06	0.000113	CcSEcCtD
Daunorubicin—Hyperhidrosis—Methotrexate—breast cancer	4.32e-06	0.000112	CcSEcCtD
Daunorubicin—Discomfort—Epirubicin—breast cancer	4.31e-06	0.000112	CcSEcCtD
Daunorubicin—Asthenia—Capecitabine—breast cancer	4.31e-06	0.000112	CcSEcCtD
Daunorubicin—Malaise—Doxorubicin—breast cancer	4.27e-06	0.000111	CcSEcCtD
Daunorubicin—Dry mouth—Epirubicin—breast cancer	4.26e-06	0.000111	CcSEcCtD
Daunorubicin—Anorexia—Methotrexate—breast cancer	4.26e-06	0.00011	CcSEcCtD
Daunorubicin—Syncope—Doxorubicin—breast cancer	4.25e-06	0.00011	CcSEcCtD
Daunorubicin—Pruritus—Capecitabine—breast cancer	4.25e-06	0.00011	CcSEcCtD
Daunorubicin—Leukopenia—Doxorubicin—breast cancer	4.24e-06	0.00011	CcSEcCtD
Daunorubicin—Diarrhoea—Docetaxel—breast cancer	4.24e-06	0.00011	CcSEcCtD
Daunorubicin—Confusional state—Epirubicin—breast cancer	4.22e-06	0.000109	CcSEcCtD
Daunorubicin—Palpitations—Doxorubicin—breast cancer	4.19e-06	0.000109	CcSEcCtD
Daunorubicin—Oedema—Epirubicin—breast cancer	4.18e-06	0.000108	CcSEcCtD
Daunorubicin—Anaphylactic shock—Epirubicin—breast cancer	4.18e-06	0.000108	CcSEcCtD
Daunorubicin—Loss of consciousness—Doxorubicin—breast cancer	4.17e-06	0.000108	CcSEcCtD
Daunorubicin—Infection—Epirubicin—breast cancer	4.15e-06	0.000108	CcSEcCtD
Daunorubicin—Cough—Doxorubicin—breast cancer	4.14e-06	0.000107	CcSEcCtD
Daunorubicin—Shock—Epirubicin—breast cancer	4.11e-06	0.000107	CcSEcCtD
Daunorubicin—Convulsion—Doxorubicin—breast cancer	4.11e-06	0.000107	CcSEcCtD
Daunorubicin—Diarrhoea—Capecitabine—breast cancer	4.11e-06	0.000107	CcSEcCtD
Daunorubicin—Dizziness—Docetaxel—breast cancer	4.1e-06	0.000106	CcSEcCtD
Daunorubicin—Thrombocytopenia—Epirubicin—breast cancer	4.09e-06	0.000106	CcSEcCtD
Daunorubicin—Hypertension—Doxorubicin—breast cancer	4.09e-06	0.000106	CcSEcCtD
Daunorubicin—Tachycardia—Epirubicin—breast cancer	4.08e-06	0.000106	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Methotrexate—breast cancer	4.07e-06	0.000106	CcSEcCtD
Daunorubicin—Hyperhidrosis—Epirubicin—breast cancer	4.04e-06	0.000105	CcSEcCtD
Daunorubicin—Insomnia—Methotrexate—breast cancer	4.04e-06	0.000105	CcSEcCtD
Daunorubicin—Arthralgia—Doxorubicin—breast cancer	4.04e-06	0.000105	CcSEcCtD
Daunorubicin—Chest pain—Doxorubicin—breast cancer	4.04e-06	0.000105	CcSEcCtD
Daunorubicin—Myalgia—Doxorubicin—breast cancer	4.04e-06	0.000105	CcSEcCtD
Daunorubicin—Anxiety—Doxorubicin—breast cancer	4.02e-06	0.000104	CcSEcCtD
Daunorubicin—Discomfort—Doxorubicin—breast cancer	3.99e-06	0.000103	CcSEcCtD
Daunorubicin—Anorexia—Epirubicin—breast cancer	3.98e-06	0.000103	CcSEcCtD
Daunorubicin—Dyspnoea—Methotrexate—breast cancer	3.98e-06	0.000103	CcSEcCtD
Daunorubicin—Somnolence—Methotrexate—breast cancer	3.97e-06	0.000103	CcSEcCtD
Daunorubicin—Dizziness—Capecitabine—breast cancer	3.97e-06	0.000103	CcSEcCtD
Daunorubicin—Dry mouth—Doxorubicin—breast cancer	3.95e-06	0.000102	CcSEcCtD
Daunorubicin—Vomiting—Docetaxel—breast cancer	3.94e-06	0.000102	CcSEcCtD
Daunorubicin—Rash—Docetaxel—breast cancer	3.91e-06	0.000101	CcSEcCtD
Daunorubicin—Dermatitis—Docetaxel—breast cancer	3.9e-06	0.000101	CcSEcCtD
Daunorubicin—Confusional state—Doxorubicin—breast cancer	3.9e-06	0.000101	CcSEcCtD
Daunorubicin—Decreased appetite—Methotrexate—breast cancer	3.88e-06	0.000101	CcSEcCtD
Daunorubicin—Headache—Docetaxel—breast cancer	3.88e-06	0.000101	CcSEcCtD
Daunorubicin—Oedema—Doxorubicin—breast cancer	3.87e-06	0.0001	CcSEcCtD
Daunorubicin—Anaphylactic shock—Doxorubicin—breast cancer	3.87e-06	0.0001	CcSEcCtD
Daunorubicin—Fatigue—Methotrexate—breast cancer	3.85e-06	9.99e-05	CcSEcCtD
Daunorubicin—Infection—Doxorubicin—breast cancer	3.84e-06	9.97e-05	CcSEcCtD
Daunorubicin—Pain—Methotrexate—breast cancer	3.82e-06	9.91e-05	CcSEcCtD
Daunorubicin—Vomiting—Capecitabine—breast cancer	3.82e-06	9.9e-05	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Epirubicin—breast cancer	3.81e-06	9.88e-05	CcSEcCtD
Daunorubicin—Shock—Doxorubicin—breast cancer	3.81e-06	9.87e-05	CcSEcCtD
Daunorubicin—Thrombocytopenia—Doxorubicin—breast cancer	3.79e-06	9.83e-05	CcSEcCtD
Daunorubicin—Rash—Capecitabine—breast cancer	3.78e-06	9.82e-05	CcSEcCtD
Daunorubicin—Insomnia—Epirubicin—breast cancer	3.78e-06	9.81e-05	CcSEcCtD
Daunorubicin—Dermatitis—Capecitabine—breast cancer	3.78e-06	9.81e-05	CcSEcCtD
Daunorubicin—Tachycardia—Doxorubicin—breast cancer	3.78e-06	9.79e-05	CcSEcCtD
Daunorubicin—Headache—Capecitabine—breast cancer	3.76e-06	9.75e-05	CcSEcCtD
Daunorubicin—Hyperhidrosis—Doxorubicin—breast cancer	3.74e-06	9.7e-05	CcSEcCtD
Daunorubicin—Dyspnoea—Epirubicin—breast cancer	3.73e-06	9.67e-05	CcSEcCtD
Daunorubicin—Somnolence—Epirubicin—breast cancer	3.72e-06	9.64e-05	CcSEcCtD
Daunorubicin—Anorexia—Doxorubicin—breast cancer	3.69e-06	9.57e-05	CcSEcCtD
Daunorubicin—Nausea—Docetaxel—breast cancer	3.68e-06	9.55e-05	CcSEcCtD
Daunorubicin—Feeling abnormal—Methotrexate—breast cancer	3.68e-06	9.55e-05	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Methotrexate—breast cancer	3.65e-06	9.48e-05	CcSEcCtD
Daunorubicin—Decreased appetite—Epirubicin—breast cancer	3.63e-06	9.43e-05	CcSEcCtD
Daunorubicin—Fatigue—Epirubicin—breast cancer	3.6e-06	9.35e-05	CcSEcCtD
Daunorubicin—Constipation—Epirubicin—breast cancer	3.57e-06	9.28e-05	CcSEcCtD
Daunorubicin—Pain—Epirubicin—breast cancer	3.57e-06	9.28e-05	CcSEcCtD
Daunorubicin—Nausea—Capecitabine—breast cancer	3.56e-06	9.25e-05	CcSEcCtD
Daunorubicin—Urticaria—Methotrexate—breast cancer	3.55e-06	9.21e-05	CcSEcCtD
Daunorubicin—Body temperature increased—Methotrexate—breast cancer	3.53e-06	9.16e-05	CcSEcCtD
Daunorubicin—Abdominal pain—Methotrexate—breast cancer	3.53e-06	9.16e-05	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.52e-06	9.14e-05	CcSEcCtD
Daunorubicin—Insomnia—Doxorubicin—breast cancer	3.5e-06	9.08e-05	CcSEcCtD
Daunorubicin—Dyspnoea—Doxorubicin—breast cancer	3.45e-06	8.95e-05	CcSEcCtD
Daunorubicin—Feeling abnormal—Epirubicin—breast cancer	3.44e-06	8.94e-05	CcSEcCtD
Daunorubicin—Somnolence—Doxorubicin—breast cancer	3.44e-06	8.92e-05	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Epirubicin—breast cancer	3.42e-06	8.87e-05	CcSEcCtD
Daunorubicin—Decreased appetite—Doxorubicin—breast cancer	3.36e-06	8.72e-05	CcSEcCtD
Daunorubicin—Fatigue—Doxorubicin—breast cancer	3.33e-06	8.65e-05	CcSEcCtD
Daunorubicin—Urticaria—Epirubicin—breast cancer	3.32e-06	8.62e-05	CcSEcCtD
Daunorubicin—Pain—Doxorubicin—breast cancer	3.31e-06	8.58e-05	CcSEcCtD
Daunorubicin—Constipation—Doxorubicin—breast cancer	3.31e-06	8.58e-05	CcSEcCtD
Daunorubicin—Abdominal pain—Epirubicin—breast cancer	3.3e-06	8.57e-05	CcSEcCtD
Daunorubicin—Body temperature increased—Epirubicin—breast cancer	3.3e-06	8.57e-05	CcSEcCtD
Daunorubicin—Hypersensitivity—Methotrexate—breast cancer	3.29e-06	8.54e-05	CcSEcCtD
Daunorubicin—Asthenia—Methotrexate—breast cancer	3.21e-06	8.32e-05	CcSEcCtD
Daunorubicin—Feeling abnormal—Doxorubicin—breast cancer	3.19e-06	8.27e-05	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Doxorubicin—breast cancer	3.16e-06	8.21e-05	CcSEcCtD
Daunorubicin—Pruritus—Methotrexate—breast cancer	3.16e-06	8.2e-05	CcSEcCtD
Daunorubicin—Hypersensitivity—Epirubicin—breast cancer	3.08e-06	7.99e-05	CcSEcCtD
Daunorubicin—Urticaria—Doxorubicin—breast cancer	3.07e-06	7.97e-05	CcSEcCtD
Daunorubicin—Body temperature increased—Doxorubicin—breast cancer	3.06e-06	7.93e-05	CcSEcCtD
Daunorubicin—Abdominal pain—Doxorubicin—breast cancer	3.06e-06	7.93e-05	CcSEcCtD
Daunorubicin—Diarrhoea—Methotrexate—breast cancer	3.06e-06	7.93e-05	CcSEcCtD
Daunorubicin—Asthenia—Epirubicin—breast cancer	3e-06	7.78e-05	CcSEcCtD
Daunorubicin—Pruritus—Epirubicin—breast cancer	2.96e-06	7.67e-05	CcSEcCtD
Daunorubicin—Dizziness—Methotrexate—breast cancer	2.95e-06	7.66e-05	CcSEcCtD
Daunorubicin—Diarrhoea—Epirubicin—breast cancer	2.86e-06	7.42e-05	CcSEcCtD
Daunorubicin—Hypersensitivity—Doxorubicin—breast cancer	2.85e-06	7.39e-05	CcSEcCtD
Daunorubicin—Vomiting—Methotrexate—breast cancer	2.84e-06	7.37e-05	CcSEcCtD
Daunorubicin—Rash—Methotrexate—breast cancer	2.82e-06	7.31e-05	CcSEcCtD
Daunorubicin—Dermatitis—Methotrexate—breast cancer	2.81e-06	7.3e-05	CcSEcCtD
Daunorubicin—Headache—Methotrexate—breast cancer	2.8e-06	7.26e-05	CcSEcCtD
Daunorubicin—Asthenia—Doxorubicin—breast cancer	2.78e-06	7.2e-05	CcSEcCtD
Daunorubicin—Dizziness—Epirubicin—breast cancer	2.76e-06	7.17e-05	CcSEcCtD
Daunorubicin—Pruritus—Doxorubicin—breast cancer	2.74e-06	7.1e-05	CcSEcCtD
Daunorubicin—Vomiting—Epirubicin—breast cancer	2.66e-06	6.9e-05	CcSEcCtD
Daunorubicin—Nausea—Methotrexate—breast cancer	2.65e-06	6.88e-05	CcSEcCtD
Daunorubicin—Diarrhoea—Doxorubicin—breast cancer	2.65e-06	6.87e-05	CcSEcCtD
Daunorubicin—Rash—Epirubicin—breast cancer	2.64e-06	6.84e-05	CcSEcCtD
Daunorubicin—Dermatitis—Epirubicin—breast cancer	2.63e-06	6.83e-05	CcSEcCtD
Daunorubicin—Headache—Epirubicin—breast cancer	2.62e-06	6.79e-05	CcSEcCtD
Daunorubicin—Dizziness—Doxorubicin—breast cancer	2.56e-06	6.64e-05	CcSEcCtD
Daunorubicin—Nausea—Epirubicin—breast cancer	2.48e-06	6.44e-05	CcSEcCtD
Daunorubicin—Vomiting—Doxorubicin—breast cancer	2.46e-06	6.38e-05	CcSEcCtD
Daunorubicin—Rash—Doxorubicin—breast cancer	2.44e-06	6.33e-05	CcSEcCtD
Daunorubicin—Dermatitis—Doxorubicin—breast cancer	2.44e-06	6.32e-05	CcSEcCtD
Daunorubicin—Headache—Doxorubicin—breast cancer	2.42e-06	6.29e-05	CcSEcCtD
Daunorubicin—Nausea—Doxorubicin—breast cancer	2.3e-06	5.96e-05	CcSEcCtD
Daunorubicin—CYP1A2—Metabolism—DPYD—breast cancer	4.29e-07	1.72e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NCOA2—breast cancer	4.28e-07	1.72e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTGS2—breast cancer	4.28e-07	1.71e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALDOA—breast cancer	4.22e-07	1.69e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.18e-07	1.67e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	4.16e-07	1.67e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTEN—breast cancer	4.16e-07	1.67e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CG—breast cancer	4.15e-07	1.66e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—FASN—breast cancer	4.15e-07	1.66e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CD—breast cancer	4.15e-07	1.66e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—COMT—breast cancer	4.14e-07	1.66e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—BCHE—breast cancer	4.14e-07	1.66e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ABCB1—breast cancer	4.13e-07	1.65e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTP1—breast cancer	4.12e-07	1.65e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CG—breast cancer	4.11e-07	1.65e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NCOA3—breast cancer	4.1e-07	1.64e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ALB—breast cancer	4.1e-07	1.64e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC5A5—breast cancer	4.09e-07	1.64e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC2A2—breast cancer	4.07e-07	1.63e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—HMOX1—breast cancer	4.06e-07	1.63e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTA4—breast cancer	4.06e-07	1.63e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CA9—breast cancer	4.06e-07	1.63e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—TYMS—breast cancer	4.05e-07	1.62e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ITPR1—breast cancer	4.05e-07	1.62e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDKN1B—breast cancer	4.05e-07	1.62e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.03e-07	1.61e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CD—breast cancer	4.01e-07	1.61e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PLA2G4A—breast cancer	4.01e-07	1.61e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—NCOR1—breast cancer	4.01e-07	1.61e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTM1—breast cancer	4.01e-07	1.61e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CPT1A—breast cancer	3.98e-07	1.6e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—MTR—breast cancer	3.98e-07	1.6e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ABCG2—breast cancer	3.98e-07	1.6e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CA—breast cancer	3.98e-07	1.59e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ALB—breast cancer	3.96e-07	1.59e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTA2—breast cancer	3.95e-07	1.58e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GPX2—breast cancer	3.95e-07	1.58e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NQO1—breast cancer	3.95e-07	1.58e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC2A1—breast cancer	3.95e-07	1.58e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—NOS3—breast cancer	3.92e-07	1.57e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HPGDS—breast cancer	3.91e-07	1.57e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SULT1A1—breast cancer	3.91e-07	1.56e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GPX4—breast cancer	3.91e-07	1.56e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ABCB1—breast cancer	3.9e-07	1.56e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HBA1—breast cancer	3.88e-07	1.56e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP3A4—breast cancer	3.85e-07	1.54e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GPX1—breast cancer	3.84e-07	1.54e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—TYMS—breast cancer	3.83e-07	1.53e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CTNNB1—breast cancer	3.83e-07	1.53e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—IDH1—breast cancer	3.82e-07	1.53e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTA1—breast cancer	3.82e-07	1.53e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP1A1—breast cancer	3.8e-07	1.52e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTT1—breast cancer	3.79e-07	1.52e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ACHE—breast cancer	3.79e-07	1.52e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—NOS3—breast cancer	3.79e-07	1.52e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PLA2G4A—breast cancer	3.79e-07	1.52e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—NCOR1—breast cancer	3.79e-07	1.52e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTM1—breast cancer	3.79e-07	1.52e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP1B1—breast cancer	3.78e-07	1.52e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NAT2—breast cancer	3.77e-07	1.51e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ERCC2—breast cancer	3.77e-07	1.51e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	3.76e-07	1.51e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDKN1A—breast cancer	3.74e-07	1.5e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTEN—breast cancer	3.73e-07	1.49e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—HSP90AA1—breast cancer	3.71e-07	1.49e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CD—breast cancer	3.65e-07	1.46e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GPX1—breast cancer	3.63e-07	1.45e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CB—breast cancer	3.62e-07	1.45e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CD—breast cancer	3.61e-07	1.45e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NCOA1—breast cancer	3.61e-07	1.45e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ALB—breast cancer	3.6e-07	1.44e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP17A1—breast cancer	3.59e-07	1.44e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTGS2—breast cancer	3.58e-07	1.44e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ALB—breast cancer	3.57e-07	1.43e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ERCC2—breast cancer	3.56e-07	1.43e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—STK11—breast cancer	3.56e-07	1.42e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP19A1—breast cancer	3.56e-07	1.42e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS1—breast cancer	3.55e-07	1.42e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ENO1—breast cancer	3.55e-07	1.42e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—MTHFR—breast cancer	3.54e-07	1.42e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.54e-07	1.42e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CB—breast cancer	3.5e-07	1.4e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.49e-07	1.4e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP2D6—breast cancer	3.48e-07	1.4e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTGS2—breast cancer	3.47e-07	1.39e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SRC—breast cancer	3.46e-07	1.39e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—NOS3—breast cancer	3.45e-07	1.38e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NCOA2—breast cancer	3.42e-07	1.37e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—NOS3—breast cancer	3.41e-07	1.37e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—MTHFR—breast cancer	3.35e-07	1.34e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—STAT3—breast cancer	3.34e-07	1.34e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—FASN—breast cancer	3.32e-07	1.33e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—DPYD—breast cancer	3.31e-07	1.33e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—MED12—breast cancer	3.31e-07	1.33e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—COMT—breast cancer	3.31e-07	1.32e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—BCHE—breast cancer	3.3e-07	1.32e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTP1—breast cancer	3.29e-07	1.32e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CAV1—breast cancer	3.27e-07	1.31e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC5A5—breast cancer	3.26e-07	1.31e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALDOA—breast cancer	3.26e-07	1.3e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—AKT1—breast cancer	3.25e-07	1.3e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—HMOX1—breast cancer	3.25e-07	1.3e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ITPR1—breast cancer	3.24e-07	1.3e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MAPK3—breast cancer	3.19e-07	1.28e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CB—breast cancer	3.18e-07	1.27e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NCOA3—breast cancer	3.16e-07	1.27e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTGS2—breast cancer	3.15e-07	1.26e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC2A1—breast cancer	3.15e-07	1.26e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NQO1—breast cancer	3.15e-07	1.26e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CB—breast cancer	3.15e-07	1.26e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC2A2—breast cancer	3.14e-07	1.26e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTEN—breast cancer	3.13e-07	1.25e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS2—breast cancer	3.12e-07	1.25e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MYC—breast cancer	3.1e-07	1.24e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TGFB1—breast cancer	3.09e-07	1.24e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CAV1—breast cancer	3.09e-07	1.24e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.08e-07	1.24e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—MTR—breast cancer	3.08e-07	1.23e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CPT1A—breast cancer	3.08e-07	1.23e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ABCG2—breast cancer	3.08e-07	1.23e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP3A4—breast cancer	3.07e-07	1.23e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TYMS—breast cancer	3.06e-07	1.23e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.06e-07	1.22e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EGFR—breast cancer	3.03e-07	1.22e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NCOR1—breast cancer	3.02e-07	1.21e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PLA2G4A—breast cancer	3.02e-07	1.21e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTM1—breast cancer	3.02e-07	1.21e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTEN—breast cancer	3.02e-07	1.21e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP1B1—breast cancer	3.02e-07	1.21e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HPGDS—breast cancer	3.02e-07	1.21e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HBA1—breast cancer	3e-07	1.2e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CG—breast cancer	2.98e-07	1.19e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.96e-07	1.19e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.95e-07	1.18e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CA—breast cancer	2.94e-07	1.18e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ACHE—breast cancer	2.93e-07	1.17e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTT1—breast cancer	2.93e-07	1.17e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GPX1—breast cancer	2.9e-07	1.16e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NCOA1—breast cancer	2.88e-07	1.15e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP1A1—breast cancer	2.87e-07	1.15e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—KRAS—breast cancer	2.87e-07	1.15e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ERCC2—breast cancer	2.84e-07	1.14e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP19A1—breast cancer	2.84e-07	1.14e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—STK11—breast cancer	2.84e-07	1.14e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CG—breast cancer	2.81e-07	1.13e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP17A1—breast cancer	2.77e-07	1.11e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTEN—breast cancer	2.75e-07	1.1e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS1—breast cancer	2.74e-07	1.1e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ENO1—breast cancer	2.74e-07	1.1e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTEN—breast cancer	2.72e-07	1.09e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP2D6—breast cancer	2.69e-07	1.08e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—MTHFR—breast cancer	2.67e-07	1.07e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.67e-07	1.07e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—COMT—breast cancer	2.64e-07	1.06e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NCOA2—breast cancer	2.64e-07	1.06e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CA—breast cancer	2.63e-07	1.05e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTP1—breast cancer	2.63e-07	1.05e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CD—breast cancer	2.62e-07	1.05e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HMOX1—breast cancer	2.59e-07	1.04e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ITPR1—breast cancer	2.59e-07	1.04e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ALB—breast cancer	2.58e-07	1.03e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—FASN—breast cancer	2.56e-07	1.03e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—BCHE—breast cancer	2.55e-07	1.02e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC5A5—breast cancer	2.52e-07	1.01e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ABCB1—breast cancer	2.49e-07	9.96e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CD—breast cancer	2.47e-07	9.9e-06	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—NOS3—breast cancer	2.47e-07	9.9e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CAV1—breast cancer	2.47e-07	9.88e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TYMS—breast cancer	2.44e-07	9.78e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ALB—breast cancer	2.44e-07	9.77e-06	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HRAS—breast cancer	2.44e-07	9.76e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC2A1—breast cancer	2.43e-07	9.74e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NQO1—breast cancer	2.43e-07	9.74e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NCOR1—breast cancer	2.41e-07	9.67e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.41e-07	9.67e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTM1—breast cancer	2.41e-07	9.67e-06	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AKT1—breast cancer	2.4e-07	9.6e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—NOS3—breast cancer	2.33e-07	9.35e-06	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—IL6—breast cancer	2.33e-07	9.34e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP1B1—breast cancer	2.33e-07	9.34e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GPX1—breast cancer	2.31e-07	9.26e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP1A1—breast cancer	2.29e-07	9.17e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.29e-07	9.16e-06	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CB—breast cancer	2.28e-07	9.13e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ERCC2—breast cancer	2.27e-07	9.09e-06	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS2—breast cancer	2.26e-07	9.05e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CG—breast cancer	2.25e-07	8.99e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NCOA1—breast cancer	2.22e-07	8.91e-06	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CA—breast cancer	2.2e-07	8.83e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—STK11—breast cancer	2.19e-07	8.78e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP19A1—breast cancer	2.19e-07	8.78e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CB—breast cancer	2.15e-07	8.63e-06	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKT1—breast cancer	2.15e-07	8.61e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS2—breast cancer	2.13e-07	8.55e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—MTHFR—breast cancer	2.13e-07	8.55e-06	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CA—breast cancer	2.13e-07	8.54e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—COMT—breast cancer	2.04e-07	8.16e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTP1—breast cancer	2.03e-07	8.12e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HMOX1—breast cancer	2e-07	8.01e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ITPR1—breast cancer	2e-07	7.99e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CD—breast cancer	1.97e-07	7.91e-06	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTEN—breast cancer	1.97e-07	7.89e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CAV1—breast cancer	1.97e-07	7.88e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ALB—breast cancer	1.95e-07	7.81e-06	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CA—breast cancer	1.94e-07	7.77e-06	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CA—breast cancer	1.92e-07	7.69e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ABCB1—breast cancer	1.92e-07	7.69e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TYMS—breast cancer	1.89e-07	7.55e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.88e-07	7.53e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NOS3—breast cancer	1.86e-07	7.47e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NCOR1—breast cancer	1.86e-07	7.46e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTM1—breast cancer	1.86e-07	7.46e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.86e-07	7.46e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTEN—breast cancer	1.86e-07	7.46e-06	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKT1—breast cancer	1.8e-07	7.21e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CG—breast cancer	1.79e-07	7.18e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GPX1—breast cancer	1.78e-07	7.15e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP1A1—breast cancer	1.77e-07	7.08e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ERCC2—breast cancer	1.75e-07	7.02e-06	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKT1—breast cancer	1.74e-07	6.98e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CB—breast cancer	1.72e-07	6.89e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS2—breast cancer	1.7e-07	6.83e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—MTHFR—breast cancer	1.65e-07	6.6e-06	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKT1—breast cancer	1.58e-07	6.35e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CD—breast cancer	1.58e-07	6.31e-06	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKT1—breast cancer	1.57e-07	6.28e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALB—breast cancer	1.56e-07	6.23e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CAV1—breast cancer	1.52e-07	6.08e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NOS3—breast cancer	1.49e-07	5.96e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTEN—breast cancer	1.49e-07	5.96e-06	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CA—breast cancer	1.39e-07	5.57e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CG—breast cancer	1.38e-07	5.54e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CB—breast cancer	1.37e-07	5.5e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS2—breast cancer	1.36e-07	5.45e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CA—breast cancer	1.31e-07	5.26e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CD—breast cancer	1.22e-07	4.87e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALB—breast cancer	1.2e-07	4.81e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTEN—breast cancer	1.19e-07	4.75e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NOS3—breast cancer	1.15e-07	4.6e-06	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKT1—breast cancer	1.14e-07	4.55e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKT1—breast cancer	1.07e-07	4.3e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CB—breast cancer	1.06e-07	4.25e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS2—breast cancer	1.05e-07	4.21e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CA—breast cancer	1.05e-07	4.2e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTEN—breast cancer	9.16e-08	3.67e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKT1—breast cancer	8.57e-08	3.43e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CA—breast cancer	8.37e-08	3.35e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKT1—breast cancer	6.84e-08	2.74e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CA—breast cancer	6.46e-08	2.59e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKT1—breast cancer	5.28e-08	2.11e-06	CbGpPWpGaD
